Company
Immunocore Holdings plc (IMCR)
Standardized SEC financial data for Immunocore Holdings plc — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001671927 · NASDAQ · Biological Products, (No Diagnostic Substances).
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $36.5M | $174.4M | $249.4M | $310.2M | $400.0M |
| Cost of revenue | $0 | $1.1M | $1.0M | $2.7M | $5.1M |
| Gross profit | $36.5M | $173.3M | $248.4M | $307.5M |
Standardized from Immunocore Holdings plc's SEC filings — per-share figures split-adjusted. Full history via the API.
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$143.1M | -$49.2M | $2.9M | $26.1M | -$10.7M |
| Capital expenditures | $1.4M | $2.2M |
Get IMCR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/IMCR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/IMCR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"